Oncology

News

Enhertu cleared for NHS use via Cancer Drugs Fund

NICE has recommended the use of AstraZeneca and Daiichi Sankyo's Enhertu in draft guidance, the first time the drug has been commissioned in any European country.

News

Astellas, Seagen seek speedy reviews of Padcev in bladder ca...

The next milestone in Seagen and Astellas' bid to build their antibody-drug conjugate (ADC) Padcev into a blockbuster will come in August, when the FDA concludes an accelerated review of tw

News

Gilead's Trodelvy approved in metastatic urothelial cancer

Gilead’s Trodelvy has another string to its bow after FDA approval in patients with advanced metastatic urothelial cancer.

Events

Partner Content

STING & TLR Targeting Therapies Summit

Investigating the cGAS-STING and TLR pathways

News

AI implementation for pharma and healthcare

Exscientia starts trials of first AI-derived cancer immunoth...

Exscientia was the first company to start human trials of a new drug designed using artificial intelligence (AI) last year, and now says it has started testing of the first AI candidate for

Views & Analysis